Corbus Pharmaceuticals
CRBP
$38.77
Share price
1.49%
Change (1 day)
344.61%
Change (1 year)
Categories
Earnings for Corbus Pharmaceuticals (CRBP)
Earnings in 2023 (TTM): -$45.49 M
According to Corbus Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -$45.49 M. In 2022 the company made an earning of -$34.9 M an increase over its 2021 earnings that were of -$55.99 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Corbus Pharmaceuticals from 2014 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$45.49 M | 30.36% |
| 2022 | -$34.9 M | -37.68% |
| 2021 | -$55.99 M | -54.41% |
| 2020 | -$0.13 B | 59.28% |
| 2019 | -$77.11 M | 35.87% |
| 2018 | -$56.75 M | 74.27% |
| 2017 | -$32.57 M | 62.94% |
| 2016 | -$19.99 M | 125.82% |
| 2015 | -$8.85 M | 251.68% |
| 2014 | -$2.52 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Viking Therapeutics
VKTX | -$93.72 M | 106.03% | 🇺🇸 USA |
 Vanda Pharmaceuticals VNDA | -$13.96 M | -69.33% | 🇺🇸 USA |
 Epizyme EPZM | -$0.19 B | 303.61% | 🇺🇸 USA |
 Advaxis ADXS | -$34.03 M | -25.20% | 🇺🇸 USA |